Φορτώνει......
Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
Although selective metabolic and receptor-based molecular agents will surely be included in the future of prostate cancer diagnosis and therapy, currently available inorganic compounds—such as (18)F-NaF for the diagnosis of bony disease and (223)RaCl(2) for the therapy of bone metastases—were recent...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Nucl Med |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Society of Nuclear Medicine
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5093914/ https://ncbi.nlm.nih.gov/pubmed/27694165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.170746 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|